A human cell-free translation screen identifies the NT-2 mycotoxin as a ribosomal inhibitor that binds the peptidyl transferase center
Nino Schwaller, Dominic Andenmatten, Jonas Luginbühl…·Evangelos D. Karousis
Author
University of BernORCID 0000-0002-0390-0181Unclaimed ORCID profile · follow to get notified of new preprints
7 papers
Recent·Most cited
Nino Schwaller, Dominic Andenmatten, Jonas Luginbühl…·Evangelos D. Karousis
Jana Ziegelmüller, Nikolaos Kouvelas, Nino Schwaller…·Evangelos D. Karousis
The paper presents a scalable method for preparing cell-type-specific lysates from human cell lines to improve cell-free translation systems.
Emilie Bäumlin, Dominic Andenmatten, Jonas Luginbühl…·Evangelos D. Karousis
This study investigates how SARS-CoV-2 and MERS-CoV Nsp1 proteins affect host mRNA degradation, revealing that Nsp1 binding to ribosomes triggers degradation independently of translation inhibition.
Lukas‐Adrian Gurzeler, Jana Ziegelmüller, Oliver Mühlemann, Evangelos D. Karousis
This paper introduces a dual centrifugation method to produce human translation-competent lysates, enabling efficient mRNA translation in both cap-dependent and IRES-mediated ways.
Evangelos D. Karousis, Foivos Gypas, Mihaela Zavolan, Oliver Mühlemann
The paper uses long-read sequencing to identify novel NMD-sensitive mRNAs and reveals features of their biogenesis and biological role.
Katharina Noel Schubert, Evangelos D. Karousis, Ahmad Jomaa…·Nenad Ban
This study shows SARS-CoV-2 Nsp1 binds to the 40S ribosomal subunit to inhibit translation by blocking mRNA entry, while viral mRNA enhances its own translation.
Evangelos D. Karousis, Lukas‐Adrian Gurzeler, Giuditta Annibaldis…·Oliver Mühlemann
This study challenges the prevailing model of NMD by showing that ribosome stalling at stop codons does not occur during NMD activation in vitro or in vivo.